Interview with Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2. 9m 26s Download The development of safe and ...
We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback